it's not takeda's. >> right.s and you're orphan, so to speak. >> in many ways, but at the same time, they share the upside, because the deal which was excellent for us, we did not pay cash, we paid in stock so they can benefit from the upside. >> now, this morning in the "new york times," a very positive article about how they were spending less on drugs, but i'll use their language. they say that there are certain specialty drugs that cost the system a lot of money. four drugs approved in 2012, costs of nearly $200,000 per patient. that includes one of yours. article says that it's jaw-dropping, but does it save the system money? >> it's saving the system money. actually, we are in week six of the launch. and so far, we have had meetings with 32 health plans, 88 million lives covered. and so far that reimbursement has been very favorable, which means the payers are understanding the value. >> in other words, what they're saying is that we had to cover these people who had this illness. it has to be costing them

. >> one of the biggest gainers of the nasdaq on any size and they're buying back from takeda pharmaceuticalsel recovery drug. >> wouldn't you love to have them on your show? >> good for you. >> i blocked your show. >> it's getting tight. >> yeah. we are silently competitive. >> if i was in the new lulu lemon yoga pants i would be sweating through them now. it's getting hot in here. >> i wouldn't stink. >> the market demands transparency and they're getting it from lulu lemon. >> big time. big time. >> how long were you practicing that line? >> no, i just made it up right now. >> you want to go sexist? will mandy be on lulu tonight? >> why isn't sexist? >> it could be a man or woman, anybody! >> you trash a lot of icons and idols on the show. you're not afraid! >> no, i'm not. because i'm a foot taller than anybody else on the networks. >> he would step on me. >> you're a nose tackle and at 3-4, you're going to be incredible. >> cardinal health down 6% declining on the back of abc amerisourcebergen and walgreens signing a ten-year deal so essentially blocking cah out. so that is a problem for